DrugDashboards

Duloxetine D/R

Duloxetine D/R · DULOXETINE HYDROCHLORIDE 30 mg/1 · Capsule, Delayed Release · Oral · Direct_Rx

NDC 72189-0615-30 · 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA090694
TE code
AB
Approval date
Dec 11, 2013
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Duloxetine D/R (Capsule, Delayed Release)

LabelerStrengthFirst seenLast seen
Direct_RxDULOXETINE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Direct_RxDULOXETINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Sep 2, 2026
Direct_RxDULOXETINE HYDROCHLORIDE 30 mg/1Jul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Duloxetine D/R — NDC 72189-0615-30," retrieved September 3, 2026, https://drugdashboards.com/drug/72189061530.

Free to cite with attribution — see how the data is put together.